カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の皮下植込み型除細動器市場2022年：心室性頻脈、肥大型心筋症、心室性異形成症、その他

◆英語タイトル：Global Subcutaneous Implantable Cardioverter Defibrillator Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8427 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：98 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

皮下植込み型除細動器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の皮下植込み型除細動器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

皮下植込み型除細動器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・心室性頻脈、肥大型心筋症、心室性異形成症、その他

用途別セグメントは次のように区分されます。
・病院、専門クリニック、外来手術センター、在宅医療

世界の皮下植込み型除細動器市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、皮下植込み型除細動器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な皮下植込み型除細動器メーカーの企業概要、2019年～2022年までの皮下植込み型除細動器の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な皮下植込み型除細動器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別皮下植込み型除細動器の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの皮下植込み型除細動器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での皮下植込み型除細動器市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および皮下植込み型除細動器の産業チェーンを掲載しています。
・第13、14、15章では、皮下植込み型除細動器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：心室性頻脈、肥大型心筋症、心室性異形成症、その他
・用途別分析2017年-2028年：病院、専門クリニック、外来手術センター、在宅医療
・皮下植込み型除細動器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・皮下植込み型除細動器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・皮下植込み型除細動器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・皮下植込み型除細動器の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・皮下植込み型除細動器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Subcutaneous Implantable Cardioverter Defibrillator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Subcutaneous Implantable Cardioverter Defibrillator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Subcutaneous Implantable Cardioverter Defibrillator global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ventricular Tachycardia segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Subcutaneous Implantable Cardioverter Defibrillator include Abbott, Koninklijke Philips, Nihon Kohden Corporation, Medtronic, and Boston Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Subcutaneous Implantable Cardioverter Defibrillator market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ventricular Tachycardia
Hypertrophic Cardiomyopathy
Ventricular Dysplasia
Others
Market segment by Application can be divided into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Care
The key market players for global Subcutaneous Implantable Cardioverter Defibrillator market are listed below:
Abbott
Koninklijke Philips
Nihon Kohden Corporation
Medtronic
Boston Scientific
MicroPort Scientific
ClearPoint Neuro
BIOTRONIK SE
ZOLL Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Implantable Cardioverter Defibrillator product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Subcutaneous Implantable Cardioverter Defibrillator, with price, sales, revenue and global market share of Subcutaneous Implantable Cardioverter Defibrillator from 2019 to 2022.
Chapter 3, the Subcutaneous Implantable Cardioverter Defibrillator competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Implantable Cardioverter Defibrillator breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Implantable Cardioverter Defibrillator market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Subcutaneous Implantable Cardioverter Defibrillator.
Chapter 13, 14, and 15, to describe Subcutaneous Implantable Cardioverter Defibrillator sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Subcutaneous Implantable Cardioverter Defibrillator Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ventricular Tachycardia
1.2.3 Hypertrophic Cardiomyopathy
1.2.4 Ventricular Dysplasia
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Home Care
1.4 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size & Forecast
1.4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume (2017-2028)
1.4.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price (2017-2028)
1.5 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity Analysis
1.5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Total Production Capacity (2017-2028)
1.5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Implantable Cardioverter Defibrillator Market Drivers
1.6.2 Subcutaneous Implantable Cardioverter Defibrillator Market Restraints
1.6.3 Subcutaneous Implantable Cardioverter Defibrillator Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.1.4 Abbott Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Koninklijke Philips
2.2.1 Koninklijke Philips Details
2.2.2 Koninklijke Philips Major Business
2.2.3 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.2.4 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Nihon Kohden Corporation
2.3.1 Nihon Kohden Corporation Details
2.3.2 Nihon Kohden Corporation Major Business
2.3.3 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.3.4 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.4.4 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.5.4 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 MicroPort Scientific
2.6.1 MicroPort Scientific Details
2.6.2 MicroPort Scientific Major Business
2.6.3 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.6.4 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ClearPoint Neuro
2.7.1 ClearPoint Neuro Details
2.7.2 ClearPoint Neuro Major Business
2.7.3 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.7.4 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BIOTRONIK SE
2.8.1 BIOTRONIK SE Details
2.8.2 BIOTRONIK SE Major Business
2.8.3 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.8.4 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZOLL Medical
2.9.1 ZOLL Medical Details
2.9.2 ZOLL Medical Major Business
2.9.3 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.9.4 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Subcutaneous Implantable Cardioverter Defibrillator Breakdown Data by Manufacturer
3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Subcutaneous Implantable Cardioverter Defibrillator
3.4 Market Concentration Rate
3.4.1 Top 3 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer Market Share in 2021
3.4.2 Top 6 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer Market Share in 2021
3.5 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Subcutaneous Implantable Cardioverter Defibrillator Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size by Region
4.1.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Region (2017-2028)
4.1.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2028)
4.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.3 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.4 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.5 South America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.6 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Type (2017-2028)
5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
5.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Application (2017-2028)
6.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
6.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
7.2 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
7.3 North America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
7.3.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
7.3.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
8.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
8.3 Europe Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
8.3.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
8.3.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
9.2 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
9.3 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
10.2 South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
10.3 South America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
10.3.1 South America Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
10.3.2 South America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
11.2 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
11.3 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Subcutaneous Implantable Cardioverter Defibrillator and Key Manufacturers
12.2 Manufacturing Costs Percentage of Subcutaneous Implantable Cardioverter Defibrillator
12.3 Subcutaneous Implantable Cardioverter Defibrillator Production Process
12.4 Subcutaneous Implantable Cardioverter Defibrillator Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Subcutaneous Implantable Cardioverter Defibrillator Typical Distributors
13.3 Subcutaneous Implantable Cardioverter Defibrillator Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 6. Abbott Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Koninklijke Philips Basic Information, Manufacturing Base and Competitors
Table 8. Koninklijke Philips Major Business
Table 9. Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 10. Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Nihon Kohden Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Nihon Kohden Corporation Major Business
Table 13. Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 14. Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 18. Medtronic Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 20. Boston Scientific Major Business
Table 21. Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 22. Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. MicroPort Scientific Basic Information, Manufacturing Base and Competitors
Table 24. MicroPort Scientific Major Business
Table 25. MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 26. MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. ClearPoint Neuro Basic Information, Manufacturing Base and Competitors
Table 28. ClearPoint Neuro Major Business
Table 29. ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 30. ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BIOTRONIK SE Basic Information, Manufacturing Base and Competitors
Table 32. BIOTRONIK SE Major Business
Table 33. BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 34. BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ZOLL Medical Basic Information, Manufacturing Base and Competitors
Table 36. ZOLL Medical Major Business
Table 37. ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Product and Services
Table 38. ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Subcutaneous Implantable Cardioverter Defibrillator, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Subcutaneous Implantable Cardioverter Defibrillator Production Site of Key Manufacturer
Table 44. Subcutaneous Implantable Cardioverter Defibrillator New Entrant and Capacity Expansion Plans
Table 45. Subcutaneous Implantable Cardioverter Defibrillator Mergers & Acquisitions in the Past Five Years
Table 46. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2017-2022) & (K Units)
Table 47. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2023-2028) & (K Units)
Table 48. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 51. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 52. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 57. Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 58. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2022) & (K Units)
Table 63. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2023-2028) & (K Units)
Table 64. North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 67. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 68. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 69. North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 70. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2022) & (K Units)
Table 71. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2023-2028) & (K Units)
Table 72. Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 75. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 76. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 77. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 86. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2022) & (K Units)
Table 87. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2023-2028) & (K Units)
Table 88. South America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 91. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 92. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 93. South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2023-2028) & (K Units)
Table 102. Subcutaneous Implantable Cardioverter Defibrillator Raw Material
Table 103. Key Manufacturers of Subcutaneous Implantable Cardioverter Defibrillator Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Subcutaneous Implantable Cardioverter Defibrillator Typical Distributors
Table 107. Subcutaneous Implantable Cardioverter Defibrillator Typical Customers
List of Figures
Figure 1. Subcutaneous Implantable Cardioverter Defibrillator Picture
Figure 2. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Type in 2021
Figure 3. Ventricular Tachycardia
Figure 4. Hypertrophic Cardiomyopathy
Figure 5. Ventricular Dysplasia
Figure 6. Others
Figure 7. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Home Care
Figure 12. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Subcutaneous Implantable Cardioverter Defibrillator Sales (2017-2028) & (K Units)
Figure 15. Global Subcutaneous Implantable Cardioverter Defibrillator Price (2017-2028) & (US$/Unit)
Figure 16. Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity (2017-2028) & (K Units)
Figure 17. Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Subcutaneous Implantable Cardioverter Defibrillator Market Drivers
Figure 19. Subcutaneous Implantable Cardioverter Defibrillator Market Restraints
Figure 20. Subcutaneous Implantable Cardioverter Defibrillator Market Trends
Figure 21. Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Manufacturer in 2021
Figure 22. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Manufacturer in 2021
Figure 23. Subcutaneous Implantable Cardioverter Defibrillator Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Region (2017-2028)
Figure 27. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Region (2017-2028)
Figure 28. North America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028) & (USD Million)
Figure 29. Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028) & (USD Million)
Figure 31. South America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028) & (USD Million)
Figure 33. Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
Figure 34. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Type (2017-2028)
Figure 35. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 37. Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Application (2017-2028)
Figure 38. Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
Figure 40. North America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 41. North America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Country (2017-2028)
Figure 42. North America Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Country (2017-2028)
Figure 43. United States Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
Figure 47. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 48. Europe Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Country (2017-2028)
Figure 49. Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Country (2017-2028)
Figure 50. Germany Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Region (2017-2028)
Figure 59. China Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
Figure 66. South America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 67. South America Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Country (2017-2028)
Figure 68. South America Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Subcutaneous Implantable Cardioverter Defibrillator in 2021
Figure 80. Manufacturing Process Analysis of Subcutaneous Implantable Cardioverter Defibrillator
Figure 81. Subcutaneous Implantable Cardioverter Defibrillator Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の皮下植込み型除細動器市場2022年：心室性頻脈、肥大型心筋症、心室性異形成症、その他(Global Subcutaneous Implantable Cardioverter Defibrillator Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の皮下植込み型除細動器市場2022年：心室性頻脈、肥大型心筋症、心室性異形成症、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp